New Tool: ProSource
Check out our packaging and processing solutions finder, ProSource.

Personalized Stem Cell Therapy for Parkinson's

Researchers transformed iPSCs from the skin cells of individuals with Parkinson's disease into young neurons.

Pexels Matthias Zomer 339620
Matthias Zomer

A recent EurekAlert! article discussed a new breakthrough that could lead to the use of a patient’s own stem cells to treat Parkinson’s disease. Scientists from Scripps Research and Cardiff University developed the innovative stem cell-based therapy that uses induced pluripotent stem cells (iPSCs) derived from a patient's own skin or blood cells. The therapy aims to replace damaged neurons in the brain. 

By using the patient's own cells, the need for immunosuppression is eliminated. Successful transplantation of young iPSC-derived neurons into a rat model with Parkinson's disease demonstrated their potential to reverse symptoms. The discovery holds promise for personalized therapy in Parkinson's patients, and hope for a new path to treating the disease.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts